ADAM17 and glioblastoma: TCGA data analysis of 159 GBM patients revealed either an association with no significant effects on overall survival for ADAM10 (384 d for high vs. 432 d for low expression, P = 0.6036) and for ADAM17 (442 d for high vs. 405 d for low, P = 0.5412).